Classical swine fever virus NS3 is an IRES-binding protein and increases IRES-dependent translation

Virus Research
Zailing ZhuMing Xiao

Abstract

To get more evidences for understanding the role of NS3 in viral translation, we observed the promotive effect of CSFV NS3 on IRES-mediated translation by using dicistronic and monocistronic systems containing the precise segment comprising CSFV IRES. The results for affinity chromatography and UV-crosslinking assays indicated that NS3 bound CSFV IRES and that CSFV NS5A and NS5B could reduce the IRES-NS3 interaction. Further experiments showed that the NS5A also bound the IRES and that NS3 and NS5A bound the same binding sites of the IRES, suggesting that NS3 and NS5A competitively bind the same sites in IRES RNA sequence, thus hampering the interaction CSFV NS3 and IRES. But, CSFV NS5B was not found to interact with the IRES. The inhibitive effect of NS5B on binding of CSFV NS3 to IRES was supposed to result from the NS3-NS5B interaction which has been documented.

References

Aug 14, 1996·Biochemical and Biophysical Research Communications·Y GwackJ Choe
Mar 26, 1998·Biochemical and Biophysical Research Communications·S IshidoH Hotta
Jul 11, 2001·Genes & Development·C U Hellen, P Sarnow
Sep 2, 2004·The Journal of Biological Chemistry·Timothy L TellinghuisenCharles M Rice
Mar 12, 2005·The Journal of Biological Chemistry·Sébastien BoniAnnie Cahour
Mar 24, 2005·The Journal of General Virology·Katerina I KalliampakouPenelope Mavromara
Aug 30, 2005·The Journal of Biological Chemistry·Luyun HuangCraig E Cameron
Dec 15, 2005·Journal of Virology·Angela M I Lam, David N Frick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.